Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Nektar Therapeutics (NKTR) stock climbed as Jefferies upgraded the company to buy ahead of a Phase 2b trial readout for ...

If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's appointment, including questions to ask, tests that might be ordered, and how ...

Conduit Pharmaceuticals (CDT) announces the filing of two groundbreaking patents for tapinarof, VTAMA, including a dual active cocrystal, ...

Jefferies upgraded Nektar (NKTR) to Buy from Hold with a price target of $2, up from $1. The company’s rezpegaldesleukin will report topline ...

As Match Day ended in March, 554 medical students celebrated their selection — out of some 1200 applicants — to a highly coveted dermatology residency slot. Many will eventually pursue advanced ...

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA®(tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the ...

It’s not just in your stuffy head. Seasonal allergies are getting worse as pollen season gets longer and more intense.

There are many other types of rashes with a wide variety of causes. Treatment for a rash requires the correct diagnosis and can include medication and avoiding potential triggers.  Easily ...